Related Experiment Video

Updated: Jul 3, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Dependence on PI3K/Akt signaling for malignant rhabdoid tumor cell survival

Kristen Foster1, Yong Wang, Daohong Zhou

  • 1Pathology and Laboratory, Medical University of South Carolina, Charleston, USA.

Cancer Chemotherapy and Pharmacology
|July 22, 2008
PubMed
Abstract

Insights

Malignant rhabdoid tumors (MRT) cells rely on the PI3K/Akt pathway for survival. Inhibiting this pathway or targeting growth factor receptors like IGF-1R shows promise for treating these aggressive pediatric cancers.

Area of Science:

  • Pediatric Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Malignant rhabdoid tumors (MRT) are aggressive pediatric cancers.
  • Loss of the INI1 tumor suppressor is a hallmark of MRT.
  • The PI3K/Akt pathway is implicated in cancer cell survival and growth.

Purpose of the Study:

  • Investigate the activation and significance of the PI3K/Akt pathway in MRT.
  • Determine if PI3K/Akt pathway inhibition affects MRT cell survival.
  • Explore mechanisms of PI3K/Akt pathway dysregulation in MRT.

Main Methods:

  • MTT assays to assess MRT cell line sensitivity to PI3K inhibition.
  • Western blot analysis to examine protein expression and activation.
  • Raf pulldown assays to investigate pathway interactions.

Main Results:

  • PI3K/Akt pathway inhibition significantly reduced MRT cell survival.
  • Constitutive Akt activation was observed in three of four MRT cell lines.
  • Insulin-like growth factor 1 receptor (IGF-1R) dysregulation was identified as a mechanism for pathway activation.

Conclusions:

  • The PI3K/Akt pathway is essential for MRT cell survival and growth.
  • MRT cells utilize various mechanisms, including growth factor receptor dysregulation, to activate the PI3K/Akt pathway.
  • Targeting the PI3K pathway or IGF-1R may offer novel therapeutic strategies for MRT.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...